PI-RADS: what is new and how to use it

Abstract The prostate imaging reporting and data system (PI-RADS) has revolutionized the use of magnetic resonance imaging (MRI) for the management of prostate cancer (PCa). The most recent version 2.1, PI-RADS v2.1, provides specific refinements in the performance, relaxing some recommendations which were not found to be helpful, while reinforcing and clarifying others. The interpretation of T2-weighted imaging (T2WI) in the transition zone (TZ), and the overall assessment of TZ nodules, now allows for a clearer distinction between those which are clearly benign and those which might warrant tissue sampling. Additional changes also resolve discrepancies in T2WI and diffusion-weighted imaging (DWI) of the peripheral zone (PZ). PI-RADS v2.1 is a simpler, more straightforward, and more reproducible method to better communicate between physicians regarding findings on prostate MRI..

Medienart:

Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:45

Enthalten in:

Abdominal radiology - 45(2020), 12 vom: 17. März, Seite 3951-3960

Sprache:

Englisch

Beteiligte Personen:

Dutruel, Silvina P. [VerfasserIn]
Jeph, Sunil [VerfasserIn]
Margolis, Daniel J. A. [VerfasserIn]
Wehrli, Natasha [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

Assessment
Cancer
MRI
PI-RADS
Prostate
Reporting

Anmerkungen:

© Springer Science+Business Media, LLC, part of Springer Nature 2020

doi:

10.1007/s00261-020-02482-x

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC2121670629